SCHEMBL1490162

SCHEMBL1490162

COc1c(F)cc(C(=O)Nc2csc(-c3cccc(Cl)c3)c2C(=O)O)c(F)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 2/20 0.40
▸ ACLY P53396 2/20 0.40
▸ ANO1 Q5XXA6 4/20 0.40
▸ MAPT P10636 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ TAS1R2 Q8TE23 1/20 0.36
▸ APEX1 P27695 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ ANO2 Q9NQ90 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490515 0.93 DHODH (0.40) DHODHACLYANO1MAPTMEN1
SCHEMBL1490193 0.91 DHODH (0.41) DHODHACLYANO1MAPTMEN1
SCHEMBL1490501 0.90 TAS1R3 (0.39) DHODHACLYANO1MAPTMEN1
SCHEMBL1490654 0.90 DHODH (0.41) DHODHACLYANO1MEN1KMT2A
SCHEMBL1490635 0.90 MEN1 (0.43) DHODHMEN1KMT2ANPC1HPGD
SCHEMBL1490362 0.90 DHODH (0.52) DHODHMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL1490413 0.90 ANO1 (0.46) ACLYANO1MEN1KMT2ANPC1
SCHEMBL1490385 0.89 PTGFR (0.41) DHODHANO1MEN1KMT2ANPC1
SCHEMBL1490494 0.85 MEN1 (0.40) DHODHANO1MEN1KMT2ANPC1
SCHEMBL1490379 0.85 MEN1 (0.48) DHODHANO1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 — — US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 DHODH 2153/4885ACLY 3891/4885ANO1 114/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 DHODH 2153/4885ACLY 3891/4885ANO1 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback